Luca S.

Medical communications & strategy agency serving pharmaceutical,surgical and diagnostic industry partners.

Business development / market access, and strategic consulting for early stage ophthalmic and mHealth / digital health companies.

US $1 billion in worldwide sales (Yen equivalent), ophthalmic / optometric medical device multinational based in Tokyo, with Americas headquarters in Oakland, NJ. P&L responsibility for one of the two largest overseas Topcon subsidiaries. An "ophthalmic intelligence provider" offering a combination of: 1) Diagnostic devices for retina, glaucoma, cataract, refractive, pre-test, etc. 2) Clinical Analysis Software 3) Healthcare Information Technology / Interoperable Networked Data Management solutions Responsible for a sales team of 40: - Direct US team - Latin market dealers - Canadian subsidiary - US distributors - National Accounts & Government Also: - chief business strategist - product development strategy and direction - business development / alliances / M&A - general execution Accomplishments: - repositioned and transformed company from a hardware manufacturer to a healthcare IT / data management company - authored vision and roadmap for EyeRoute Synergy, new PACS software, mHealth, and networking ecosystem and growth platform for Topcon; principle catalyst for its launch at American Academy of Ophthalmology 2010 meeting - increased consolidated sales 20% year-on-year, for first 6 months of fiscal 2010 - increased direct sales 27% over first 3 years - increased Healthcare IT sales by 75% over first 3 years - established more disciplined and equitable framework for US distribution partners of traditional devices - drove significant profitability improvement via Healthcare IT sales and operating expense reduction in a challenging environment in which the Yen dropped from 114 to 81 to the dollar (December 2007 to October 2010) - worked with Canadian subsidiary to transform from traditional optometric hardware to higher value added ophthalmic products - key driver of strategic alliances and new development activities, such Arcscan Artemis 3 high frequency anterior segment ultrasound and the collagen corneal cross linking FDA clinical trial

Ophthalmic medical device multinational generating €75 million in revenue with headquarters in Erlangen, Germany and sales throughout the globe. (Acquired by Alcon Laboratories in Fall 2007.) WaveLight, Inc. promotes its line of Allegretto Wave excimer lasers for LASIK surgery and associated diagnostic equipment and services, offering unparalleled clinical efficacy. Overview: Manages U.S. marketing team for WaveLight, a team of 6 ranging from practice marketing specialists, to a marketing communications writer and a trade show planner, plus direction for field sales force of 6. Responsible for strategic direction and go-to-market strategy, in conjunction with CEO. P&L responsibility for portfolio of $35 million in revenue. A key driver of turnaround of US operations through implementation of a new marketing & sales approach. Results: a revenue increase of 52% in $ terms (33% in € terms) for FY 2006/2007.

Medical device multinational generating $1.7 billion in revenue with manufacturing in Pennsylvania, Puerto Rico, California, Germany, the Netherlands, and sales throughout the globe. Position: Managed the Fixed Prosthetics/Ceramco product management group. Responsible for total portfolio of $90 million in revenue.

Medical device company – innovative infection control technology under review by FDA. Overview: Managed in-house mechanical, electrical, and quality systems engineers and an extended team of outside regulatory and scientific consultants, design engineers, testing laboratory personnel, intellectual property and financial/auditing professionals. Drove strategic direction and execution towards regulatory clearance and commercialization. Directly responsible to board of directors and shareholders.

Multinational commercial bank, based in Turin, Italy – One of the three largest Italian banks Overview: Directly responsible to Vice Presidents of lending groups. Direct client contact – marketing/lending officer and credit analysis. Managed committed loan portfolios of up to $2.5 billion. Credit lines consisted primarily of committed participations in multi-billion dollar, syndicated credit facilities for the purposes of working capital, acquisition, commercial paper issuance, foreign exchange, letters of credit, etc. Involved extensive coordination with Turin Head Office, as well as with other Italian and international branches. Salient clients included Lockheed Martin, GE Capital, IBM, etc.